(Press-News.org) A three-drug cocktail can eliminate the hepatitis C virus in patients far more effectively than the current two-drug regimen, according to researchers at Henry Ford Hospital.
"This study represents a remarkable advance and a potential cure for people with hepatitis C who have not responded to previous therapy," says co-author Stuart C. Gordon, M.D., section chief for the Division of Hepatology at Henry Ford Hospital.
"We will soon have a new standard of treatment for hepatitis C patients," says Dr. Gordon. "This study ushers in a new era of drug development that will provide a host of antiviral agents to treat hepatitis C, and we are now witnessing dramatic and rapid advances in how we will be able to treat these patients."
The results of the global study are in the March 31 issue of The New England Journal of Medicine.
At least 3.2 million Americans are infected with hepatitis C, a chronic viral disease affecting the liver. The Centers for Disease Control and Prevention estimates that more than 12,000 people die each year of liver disease and liver cancer associated with the hepatitis C virus.
Most people who are infected with hepatitis C remain without symptoms for years. When symptoms of advanced liver disease do occur, it is often too late to offer the current treatment regimens. The infection may lead to scarring of the liver (cirrhosis), liver cancer or the need for liver transplant.
The virus was previously spread through contact with infected blood products before 1990, and often via injection drug use or the sharing of straws during the use of cocaine. Among immigrants to the U.S. from Asian, African, Middle Eastern and Eastern European countries, the virus may have been transmitted via the use of non-sterile glass syringes used for vaccination purposes.
There is currently no vaccine for hepatitis C.
In the study, researchers randomly assigned patients to one of three groups. In all three groups, patients received peginterferon and ribavirin (the current standard of care) for four weeks. A control group (group 1) continued to receive only peginterferon–ribavirin for 44 additional weeks; group 2 received boceprevir plus peginterferon–ribavirin for 32 weeks, and patients with a detectable hepatitis C virus level at treatment week 8 received placebo plus peginterferon–ribavirin for an additional 12 weeks; and group 3 received boceprevir plus peginterferon–ribavirin for 44 weeks.
Boceprevir is a protease inhibitor, a new class of direct-acting antiviral agent that specifically targets and inhibits the replication of the hepatitis C virus.
Results showed the rate of sustained virologic response (loss of the virus) was significantly higher in the two boceprevir groups (group 2, 59%; group 3, 66%) than in the control group (21%).
Among patients with an undetectable hepatitis C virus level at treatment week 8, the rate of sustained virologic response was 86% after 32 weeks of triple therapy and 88% after 44 weeks of triple therapy. A sustained virologic response generally translates into a long-term eradication of virus, or cure.
"We can conclude that boceprevir, when added to peginterferon and ribavirin, leads to high rates of sustained virologic response in difficult-to-treat patients," explains Dr. Gordon.
In an accompanying article in the same issue of The New England Journal of Medicine, treatment of previously untreated hepatitis C patients with the same three-drug cocktail likewise showed significantly higher response rates than the current two drug regimen.
###
The study was funded by Schering-Plough (now Merck).
Drug cocktail offers new hope for hepatitis C patients
2011-03-31
ELSE PRESS RELEASES FROM THIS DATE:
Death anxiety prompts people to believe in intelligent design, reject evolution: UBC research
2011-03-31
Researchers at the University of British Columbia and Union College (Schenectady, N.Y.) have found that people's death anxiety can influence them to support theories of intelligent design and reject evolutionary theory.
Existential anxiety also prompted people to report increased liking for Michael Behe, intelligent design's main proponent, and increased disliking for evolutionary biologist Richard Dawkins
The lead author is UBC Psychology Asst. Prof. Jessica Tracy with co-authors Joshua Hart, assistant professor of psychology at Union College, and UBC psychology ...
Woman Dies in Dry Cleaning Accident in New York
2011-03-31
A woman was crushed to death at the dry cleaner where she worked. Limin Min Huang was loading towels into an industrial steamer when her scarf got caught in the machine.
The accident at work left her brain dead.
According to her manager, Huang was looking into the machine and she forgot she was wearing a scarf. The scarf became caught in the machine and it pulled her in before stopping.
There are many dangers associated with working at a dry cleaner. Chemical, fire, and ergonomic-related hazards are all risks connected to the dry cleaning processes. Dry cleaning ...
Nature study shows common lab dye is a wonder drug -- for worms
2011-03-31
This press release is available in Spanish. Basic Yellow 1, a dye used in neuroscience laboratories around the world to detect damaged protein in Alzheimer's disease, is a wonder drug for nematode worms. In a study appearing in the March 30, online edition of Nature, the dye, also known as Thioflavin T, (ThT) extended lifespan in healthy nematode worms by more than 50 percent and slowed the disease process in worms bred to mimic aspects of Alzheimer's. The research, conducted at the Buck Institute for Research on Aging, could open new ways to intervene in aging and age-related ...
The rose-red glow of star formation
2011-03-31
The object dominating this image may resemble a pool of spilled blood, but rather than being associated with death, such regions of ionised hydrogen -- known as HII regions -- are sites of creation with high rates of recent star birth. NGC 371 is an example of this; it is an open cluster surrounded by a nebula. The stars in open clusters all originate from the same diffuse HII region, and over time the majority of the hydrogen is used up by star formation, leaving behind a shell of hydrogen such as the one in this image, along with a cluster of hot young stars.
The host ...
Federal Crackdown on Offshore Accounts Continues
2011-03-31
From President Obama's earliest days in office, he made it clear that the administration would crack down on people who had previously evaded taxes through undeclared offshore bank accounts. To encourage people with undeclared accounts to come forward voluntarily, the administration offered a limited amnesty program.
Through the amnesty program, individuals with past-due taxes could disclose their unreported offshore assets and pay the back taxes while avoiding criminal charges and facing limited civil penalties. Since the announcement of the initial amnesty program, ...
Using Lifetime Gifts to Shift Assets Out of Estates
2011-03-31
Congress recently raised the lifetime gift tax exemption from $1 million to $5 million, or $10 million for married couples. This higher exemption amount provides an incentive for some people to give away their money in their lifetimes, rather than waiting until after they are gone.
Not only does lifetime giving offer the emotional benefit of seeing how the money is used during the grantor's lifetime, it also enables the grantor to shift assets out of his or her estate tax-free.
Increased Exemptions, Increased Ability to Shield Assets From Taxes
Following a year ...
Researchers find possible clues to tamoxifen resistance in breast cancer patients
2011-03-31
Breast cancer patients who become resistant to tamoxifen may have low levels of a protein called Rho GDI-alpha, according to a study published online March 30 in the Journal of the National Cancer Institute.
Women whose tumors have estrogen receptors (ERs) often take tamoxifen after surgery to prevent recurrence of the cancer and keep it from metastasizing to other parts of the body. Some patients, however, become resistant to the drug even though their tumors remain ER-positive.
To explore the mechanisms of this resistance, Suzanne Fuqua, Ph.D., professor of medicine ...
Scientists unlock mystery of how the 22nd amino acid is produced
2011-03-31
COLUMBUS, Ohio – The most recently discovered amino acid, pyrrolysine, is produced by a series of just three chemical reactions with a single precursor – the amino acid lysine, according to new research.
Scientists at Ohio State University used mass spectrometry and a series of experiments to discover how cells make the amino acid, a process that until now had been unknown.
They confirmed that pyrrolysine is made from enzymatic reactions with two lysine molecules – a surprising finding, given that some portions of its structure suggested to researchers that it might ...
Airline Safety Statistics Suggest Domestic Progress, Global Challenges
2011-03-31
While recent years have presented many challenges for Americans, one news item from last year was welcome: no fatal U.S. airline crashes occurred in 2010. Over the past two decades, the National Transportation Safety Board's statistics for major commercial aircraft accidents involving fatalities show a steady decrease from the early 1990s, despite a 50 percent increase in aircraft hours flown.
Aviation accident fatalities have never been worse than one per 15 million passengers since the devastating year of 2001. U.S. airlines have also recorded zero fatalities in three ...
UCSF researchers identify promising new treatment for childhood leukemia
2011-03-31
An experimental drug lessens symptoms of a rare form of childhood leukemia and offers significant insight into the cellular development of the disease, according to findings from a new UCSF study. The mouse model research could spearhead the development of new leukemia therapies and paves the way for future clinical trials in humans.
"Although this drug did not produce a cure, it alleviated the symptoms of leukemia as long as the treatment was continued and delayed the development of a more aggressive disease," said senior author Benjamin Braun, MD, PhD, a pediatric ...